细胞凋亡
转化生长因子
内皮干细胞
炎症
免疫学
转录因子
细胞生物学
癌症研究
医学
化学
生物
生物化学
体外
基因
作者
Zhiyu He,Hao Xue,Peiying Liu,Dunzheng Han,Lingling Xu,Xiaojun Zeng,Jinping Wang,Biqing Yang,Bihui Luo
标识
DOI:10.1097/fjc.0000000000000813
摘要
Atherosclerosis (AS), known as the chronic inflammatory disease, results from the dysfunction of vascular endothelial cells (VECs). Transforming growth factor-β1 (TGF-β1) has been reported to be induced by oxidized low-density lipoprotein (ox-LDL) and contribute to AS-related vascular endothelial cell damage. This work planned to study the mechanism of TGF-β1 in vascular endothelial cell damage. We found that TGF-β1 was activated by ox-LDL in human umbilical vascular endothelial cells (HUVECs). Silence of TGF-β1 reversed the inductive effect of ox-LDL on apoptosis and inflammatory response of HUVECs. Mechanistically, microRNA-4286 (miR-4286) targeted and inhibited TGF-β1 to inhibit Smad3, and Smad3 bound to the promoter of miR-4286 to repress its transcription. Rescue assays indicated that miR-4286 ameliorated the ox-LDL-induced apoptosis and inflammatory response through inhibiting TGF-β1. In conclusion, our study first demonstrated that miR-4286/TGF-β1/Smad3-negative feedback loop ameliorated vascular endothelial cell damage by attenuating apoptosis and inflammatory response, providing new thoughts for promoting the treatment of AS.
科研通智能强力驱动
Strongly Powered by AbleSci AI